Krystal Kang, under the supervision of the firm's lawyers, provides support on matters involving government enforcement defense and international judgment enforcement.

Her recent matters include assisting with the representation of a U.S.-based hedge fund in an ongoing cross-border investigation led by the Republic of Korea Public Prosecutor’s Office into the hedge fund’s multimillion-dollar investment in a multinational consumer electronics company. She has also assisted with representation of an Asia-based pharmaceutical company in a Section 337 investigation involving allegations of trade secret misappropriation in relation to a botulinum toxin drug before the U.S. International Trade Commission.